Soxataltinib, a highly selective CNS-penetrant RET inhibitor demonstrates durable activity in RET fusion–positive non-small cell lung cancer phase 2 study

Journal of Thoracic Oncology · Elsevier

Аннотация

Publication date: Available online 5 November 2026 Source: Journal of Thoracic Oncology Author(s): Anwen Xiong, Xiangjiao Meng, Xingya Li, Yongchang Zhang, Nong Yang, Qitao Yu, Liping Tan, Qiming Wang, Yongsheng Wang, Baogang Liu, Hui Luo, Ying Wang, Dingzhi Huang, Yiping Zhang, Feng Ye, Jian Fang, Mingfang Zhao, Yongsheng Wang, Jinghan Wang, Yan Zhu

Читать у издателя →

Похожие статьи